Back to search
FDAFDA · Food and drugs·Recall number D-0692-2026

Revitaderm Wound Care Gel, Benzalkonium Chloride 0.1%, packaged in 1.0 FL OZ (37 mL) bottle, shorter twist cap, Manufactured By: Blaine Labs, Inc. 11037 Lockport Place Santa Fe Springs, CA 90670, NDC 63347-120-02.

Published July 8, 2026 · Recall initiated: April 8, 2026

Summary

FDA records drug Class I recall D-0692-2026, published July 8, 2026 and initiated April 8, 2026. Recalling firm: Blaine Labs Inc; Status: Ongoing; Reported quantity: 1,171 - 1 oz bottles; Lot: Lot#: BL3608, Exp. 07/01/28. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Microbial contamination of Non-Sterile Product: samples identified the presence of Lysinibacillus fusiformis and other Bacillus spp

What to do

Voluntary: Firm initiated · Press Release

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Blaine Labs Inc
Distributor
Nationwide in the USA
Lot
Lot#: BL3608, Exp. 07/01/28.
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Revitaderm Wound Care Gel, Benzalkonium Chloride 0.1%, packaged in 1.0 FL OZ (37 mL) bottle, shorter twist cap, Manufactured By: Blaine Labs, Inc. 11037 Lockport Place Santa Fe Springs, CA 90670, NDC 63347-120-02. recalled?

Yes. FDA published recall D-0692-2026 on July 8, 2026. Reported hazard: Microbial contamination of Non-Sterile Product: samples identified the presence of Lysinibacillus fusiformis and other Bacillus spp

What should I do if I have this product?

Voluntary: Firm initiated · Press Release